Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Momordica charantia and type 2 diabetes: from in vitro to human studies.

Habicht SD, Ludwig C, Yang RY, Krawinkel MB.

Curr Diabetes Rev. 2014 Jan;10(1):48-60. Review.

PMID:
24295371
2.

Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.

Shetty AK, Kumar GS, Sambaiah K, Salimath PV.

Plant Foods Hum Nutr. 2005 Sep;60(3):109-12.

PMID:
16187012
3.

Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.

Krawinkel MB, Keding GB.

Nutr Rev. 2006 Jul;64(7 Pt 1):331-7. Review.

PMID:
16910221
4.

Momordica charantia for type 2 diabetes mellitus.

Ooi CP, Yassin Z, Hamid TA.

Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007845. doi: 10.1002/14651858.CD007845.pub3. Review.

PMID:
22895968
5.
6.

Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.

Wang HY, Kan WC, Cheng TJ, Yu SH, Chang LH, Chuu JJ.

Food Chem Toxicol. 2014 Jul;69:347-56. doi: 10.1016/j.fct.2014.04.008. Epub 2014 Apr 18.

PMID:
24751968
7.

Anti-inflammatory effect of Momordica charantia in sepsis mice.

Chao CY, Sung PJ, Wang WH, Kuo YH.

Molecules. 2014 Aug 21;19(8):12777-88. doi: 10.3390/molecules190812777.

8.

Antihyperglycemic effects of three extracts from Momordica charantia.

Virdi J, Sivakami S, Shahani S, Suthar AC, Banavalikar MM, Biyani MK.

J Ethnopharmacol. 2003 Sep;88(1):107-11.

PMID:
12902059
9.

Bitter melon (Momordica charantia): a review of efficacy and safety.

Basch E, Gabardi S, Ulbricht C.

Am J Health Syst Pharm. 2003 Feb 15;60(4):356-9. Review.

PMID:
12625217
10.

Modulatory effect of bitter gourd (Momordica charantia LINN.) on alterations in kidney heparan sulfate in streptozotocin-induced diabetic rats.

Kumar GS, Shetty AK, Salimath PV.

J Ethnopharmacol. 2008 Jan 17;115(2):276-83. Epub 2007 Oct 9.

PMID:
18024034
11.

Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd).

Manabe M, Takenaka R, Nakasa T, Okinaka O.

Biosci Biotechnol Biochem. 2003 Dec;67(12):2512-7.

12.

Strategies to improve palatability and increase consumption intentions for Momordica charantia (bitter melon): a vegetable commonly used for diabetes management.

Snee LS, Nerurkar VR, Dooley DA, Efird JT, Shovic AC, Nerurkar PV.

Nutr J. 2011 Jul 28;10:78. doi: 10.1186/1475-2891-10-78. Erratum in: Nutr J. 2014;13:3.

13.

Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.

Leung L, Birtwhistle R, Kotecha J, Hannah S, Cuthbertson S.

Br J Nutr. 2009 Dec;102(12):1703-8. doi: 10.1017/S0007114509992054. Review.

PMID:
19825210
14.

Bitter gourd (Momordica charantia) modulates activities of intestinal and renal disaccharidases in streptozotocin-induced diabetic rats.

Kumar Shetty A, Suresh Kumar G, Veerayya Salimath P.

Mol Nutr Food Res. 2005 Aug;49(8):791-6.

PMID:
16007724
15.

Increase in the free radical scavenging capability of bitter gourd by a heat-drying process.

Wei L, Shaoyun W, Shutao L, Jianwu Z, Lijing K, Pingfan R.

Food Funct. 2013 Dec;4(12):1850-5. doi: 10.1039/c3fo60169b. Epub 2013 Nov 6.

PMID:
24192975
16.

Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.

Mahmoud MF, El Ashry FE, El Maraghy NN, Fahmy A.

Pharm Biol. 2017 Dec;55(1):758-765. doi: 10.1080/13880209.2016.1275026.

PMID:
28064559
17.

Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities.

Yibchok-anun S, Adisakwattana S, Yao CY, Sangvanich P, Roengsumran S, Hsu WH.

Biol Pharm Bull. 2006 Jun;29(6):1126-31.

18.

Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley rats.

Uche-Nwachi EO, McEwen C.

Afr J Tradit Complement Altern Med. 2009 Oct 15;7(1):24-33.

Supplemental Content

Support Center